Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report

Mark J. Mulligan, Kirsten E. Lyke, Nicholas Kitchin, View ORCID ProfileJudith Absalon, Alejandra Gurtman, Stephen Lockhart, View ORCID ProfileKathleen Neuzil, View ORCID ProfileVanessa Raabe, Ruth Bailey, Kena A. Swanson, Ping Li, Kenneth Koury, Warren Kalina, David Cooper, Camila Fontes-Garfias, Pei-Yong Shi, Ӧzlem Türeci, Kristin R. Tompkins, Edward E. Walsh, View ORCID ProfileRobert Frenck, View ORCID ProfileAnn R. Falsey, View ORCID ProfilePhilip R. Dormitzer, William C. Gruber, Uğur Şahin, Kathrin U. Jansen
doi: https://doi.org/10.1101/2020.06.30.20142570
Mark J. Mulligan
1New York University Langone Vaccine Center and New York University Grossman School of Medicine, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kirsten E. Lyke
2University of Maryland School of Medicine, Center for Vaccine Development and Global Health, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas Kitchin
3Vaccine Research and Development, Pfizer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Judith Absalon
3Vaccine Research and Development, Pfizer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Judith Absalon
  • For correspondence: judith.absalon@pfizer.com
Alejandra Gurtman
3Vaccine Research and Development, Pfizer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Lockhart
3Vaccine Research and Development, Pfizer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathleen Neuzil
2University of Maryland School of Medicine, Center for Vaccine Development and Global Health, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kathleen Neuzil
Vanessa Raabe
1New York University Langone Vaccine Center and New York University Grossman School of Medicine, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vanessa Raabe
Ruth Bailey
3Vaccine Research and Development, Pfizer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kena A. Swanson
3Vaccine Research and Development, Pfizer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ping Li
3Vaccine Research and Development, Pfizer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth Koury
3Vaccine Research and Development, Pfizer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Warren Kalina
3Vaccine Research and Development, Pfizer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Cooper
3Vaccine Research and Development, Pfizer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Camila Fontes-Garfias
6University of Texas Medical Branch, Galveston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pei-Yong Shi
6University of Texas Medical Branch, Galveston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ӧzlem Türeci
7BioNTech, Mainz, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristin R. Tompkins
3Vaccine Research and Development, Pfizer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward E. Walsh
4University of Rochester and Rochester General Hospital, Rochester, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Frenck
5Cincinnati Children’s Hospital, Cincinnati, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robert Frenck
Ann R. Falsey
4University of Rochester and Rochester General Hospital, Rochester, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ann R. Falsey
Philip R. Dormitzer
3Vaccine Research and Development, Pfizer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Philip R. Dormitzer
William C. Gruber
3Vaccine Research and Development, Pfizer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Uğur Şahin
7BioNTech, Mainz, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathrin U. Jansen
3Vaccine Research and Development, Pfizer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2020.06.30.20142570
History 
  • July 1, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Mark J. Mulligan1,*,
  2. Kirsten E. Lyke2,*,
  3. Nicholas Kitchin*,3,a,
  4. Judith Absalon3,b,†,
  5. Alejandra Gurtman3,b,
  6. Stephen Lockhart3,a,
  7. Kathleen Neuzil2,
  8. Vanessa Raabe1,
  9. Ruth Bailey3,a,
  10. Kena A. Swanson3,b,
  11. Ping Li3,c,
  12. Kenneth Koury3,b,
  13. Warren Kalina3,b,
  14. David Cooper3,b,
  15. Camila Fontes-Garfias6,
  16. Pei-Yong Shi6,
  17. Ӧzlem Türeci7,
  18. Kristin R. Tompkins3,b,
  19. Edward E. Walsh4,
  20. Robert Frenck5,
  21. Ann R. Falsey4,
  22. Philip R. Dormitzer3,b,
  23. William C. Gruber3,b,
  24. Uğur Şahin7 and
  25. Kathrin U. Jansen3,b
  1. 1New York University Langone Vaccine Center and New York University Grossman School of Medicine, New York, NY
  2. 2University of Maryland School of Medicine, Center for Vaccine Development and Global Health, Baltimore, MD
  3. 3Vaccine Research and Development, Pfizer
  4. 4University of Rochester and Rochester General Hospital, Rochester, NY
  5. 5Cincinnati Children’s Hospital, Cincinnati, OH
  6. 6University of Texas Medical Branch, Galveston, TX
  7. 7BioNTech, Mainz, Germany
  1. ↵†Corresponding author Correspondence to Judith Absalon, MD, MPH, FIDSA judith.absalon{at}pfizer.com
  1. ↵* contributed equally

Back to top
PreviousNext
Posted July 01, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report
Mark J. Mulligan, Kirsten E. Lyke, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Kathleen Neuzil, Vanessa Raabe, Ruth Bailey, Kena A. Swanson, Ping Li, Kenneth Koury, Warren Kalina, David Cooper, Camila Fontes-Garfias, Pei-Yong Shi, Ӧzlem Türeci, Kristin R. Tompkins, Edward E. Walsh, Robert Frenck, Ann R. Falsey, Philip R. Dormitzer, William C. Gruber, Uğur Şahin, Kathrin U. Jansen
medRxiv 2020.06.30.20142570; doi: https://doi.org/10.1101/2020.06.30.20142570
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report
Mark J. Mulligan, Kirsten E. Lyke, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Kathleen Neuzil, Vanessa Raabe, Ruth Bailey, Kena A. Swanson, Ping Li, Kenneth Koury, Warren Kalina, David Cooper, Camila Fontes-Garfias, Pei-Yong Shi, Ӧzlem Türeci, Kristin R. Tompkins, Edward E. Walsh, Robert Frenck, Ann R. Falsey, Philip R. Dormitzer, William C. Gruber, Uğur Şahin, Kathrin U. Jansen
medRxiv 2020.06.30.20142570; doi: https://doi.org/10.1101/2020.06.30.20142570

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (455)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (159)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5297)
  • Forensic Medicine (3)
  • Gastroenterology (198)
  • Genetic and Genomic Medicine (760)
  • Geriatric Medicine (80)
  • Health Economics (214)
  • Health Informatics (702)
  • Health Policy (363)
  • Health Systems and Quality Improvement (224)
  • Hematology (100)
  • HIV/AIDS (165)
  • Infectious Diseases (except HIV/AIDS) (5938)
  • Intensive Care and Critical Care Medicine (368)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (772)
  • Nursing (43)
  • Nutrition (135)
  • Obstetrics and Gynecology (146)
  • Occupational and Environmental Health (234)
  • Oncology (481)
  • Ophthalmology (153)
  • Orthopedics (39)
  • Otolaryngology (97)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (138)
  • Primary Care Research (99)
  • Psychiatry and Clinical Psychology (865)
  • Public and Global Health (2035)
  • Radiology and Imaging (354)
  • Rehabilitation Medicine and Physical Therapy (159)
  • Respiratory Medicine (287)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)